Bioelectric Medicine Market Size, Share, Outlook 2018-2026
Bioelectric medicine is a new and innovative approach to diagnose and treat injuries and diseases. All major organs of the body are connected to the nerves, which allows the brain to monitor and regulate the functions of the organs. Bioelectric medicine refers to the usage of a device to modulate and read the electrical activity within the body’s nervous systems. Nerve blocking devices or nerve stimulating devices that are held against the skin or implanted on a nerve have the potential to regulate specific nerve activity, make specific changes in organ function, and also restore health, without much complicated side effects of pharmaceutical agents. Bioelectric medicine technology is used to record, block, and stimulate neural signals to change the way diseases and injuries are treated. It is also used for the treatment of conditions such as cancer, paralysis, rheumatoid arthritis, and diabetes. Electroceuticals are alternatives to drug based remedies.
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1757
Mergers and acquisitions, advancements in technology, and innovations such as non-invasive devices in the field of bioelectric medicines are the major factors driving growth of the bioelectric medicine market. For instance, in 2016, GlaxoSmithKline Plc. (GSK) merged with Google’s parent company Alphabet to set up a new bioelectric company called Galvani Bioelectronics, which will benefit over 2 billion people who are suffering from chronic diseases. GSK invested around US$ 615 million for the development of Galvani Bioelectronics. In 2015, Synapse Electroceutical Technology, a UK-based company launched a new product Accel-Heal, which is a non-invasive class 2A medical device. The device also promotes healing of leg ulcers by using electrical energy. Accel-Heal delivers a sequence of low level, pre-programmed and sub sensory electrical energy through surface of the skin.
Synapse Electroceutical Technology has a product for venous leg ulcer management in the pipeline, which is expected to fuel growth of the bioelectric medicine market over the forecast period. Other factors that boost growth of the bioelectric medicine market include increasing number of diseases in geriatric population such as cardiac arrhythmias, Parkinson’s disease, Alzheimer’s disease, epilepsy, and depression, and rise in chronic diseases such as neurological and cardiac disorders. According to a study conducted by Journal of Family Medicine and Primary Care in 2017, four major chronic diseases including cancer, cardiovascular disease, diabetes, and chronic respiratory diseases were the major cause for 82% deaths in India. According to a study conducted by World Health Organization (WHO) in 2017, non-communicable diseases are expected to contribute to death of 52 million people by 2030 globally.
Click To Continue Reading on Bioelectric Medicine Market
You may be interested
Renal Denervation Devices Market – Effective Treatment Through Minimally Invasive Catheter-Based Endovascular Procedure To Drive Market GrowthMohit Joshi - October 20, 2018
The Renal Denervation Devices Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released by Coherent Market Insights, added in its…
Transcatheter Aortic Valve Implantation (TAVI) Market – High Prevalence Of Aortic Stenosis Is Responsible For GrowthMohit Joshi - October 20, 2018
The Transcatheter Aortic Valve Implantation (TAVI) Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released by Coherent Market Insights, added…
Robotic Rehabilitation and Assistive Technologies Market – Increasing Prevalence Of Disability Around The GlobeMohit Joshi - October 20, 2018
The Robotic Rehabilitation and Assistive Technologies Market is expected to have a highly positive growth outlook from 2018-2026 according to a recently released by Coherent Market Insights, added…